argenx SE (ARGX)
USD 548.93
(-0.19%)
USD 548.93
(-0.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -425.04 Million USD | 40.94% |
| 2022 | -719.66 Million USD | -106.36% |
| 2021 | -348.74 Million USD | 32.13% |
| 2020 | -513.83 Million EUR | -156.9% |
| 2019 | -200.01 Million EUR | -113.62% |
| 2018 | -93.62 Million EUR | -240.32% |
| 2017 | -27.51 Million EUR | -22.15% |
| 2016 | -22.52 Million EUR | -32.02% |
| 2015 | -17.06 Million EUR | -30.6% |
| 2014 | -13.06 Million EUR | -51.85% |
| 2013 | -8.6 Million EUR | 35.28% |
| 2012 | -13.29 Million EUR | -181.75% |
| 2011 | -4.71 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -158.62 Million USD | -69.8% |
| 2024 Q1 | -93.42 Million USD | 36.9% |
| 2023 Q2 | -102.09 Million USD | 1.59% |
| 2023 Q1 | -103.74 Million USD | 8.8% |
| 2023 FY | -425.04 Million USD | 40.94% |
| 2023 Q3 | -80.58 Million USD | 21.06% |
| 2023 Q4 | -148.05 Million USD | -83.72% |
| 2022 Q3 | -208.63 Million USD | -19.53% |
| 2022 Q4 | -113.75 Million USD | 45.48% |
| 2022 Q1 | -222.72 Million USD | 3.55% |
| 2022 Q2 | -174.54 Million USD | 21.63% |
| 2022 FY | -719.66 Million USD | -106.36% |
| 2021 Q4 | -230.91 Million USD | -8.43% |
| 2021 FY | -348.74 Million USD | 32.13% |
| 2021 Q1 | -13 Thousand EUR | -100.01% |
| 2021 Q2 | 95.13 Million USD | 731915.38% |
| 2021 Q3 | -212.95 Million USD | -323.84% |
| 2020 Q4 | 258.02 Million USD | 353.38% |
| 2020 FY | -513.83 Million EUR | -156.9% |
| 2020 Q3 | -101.83 Million EUR | 0.0% |
| 2019 Q2 | -55.14 Million EUR | -712.86% |
| 2019 Q4 | -75.19 Million EUR | -53.81% |
| 2019 FY | -200.01 Million EUR | -113.62% |
| 2019 Q1 | -6.78 Million EUR | 82.47% |
| 2019 Q3 | -48.88 Million EUR | 11.34% |
| 2018 FY | -93.62 Million EUR | -240.32% |
| 2018 Q2 | -11.91 Million EUR | 31.7% |
| 2018 Q4 | -38.69 Million EUR | -51.23% |
| 2018 Q3 | -25.58 Million EUR | -114.78% |
| 2018 Q1 | -17.44 Million EUR | -49.3% |
| 2017 FY | -27.51 Million EUR | -22.15% |
| 2017 Q4 | -11.68 Million EUR | -44.13% |
| 2017 Q3 | -8.1 Million EUR | -749.93% |
| 2017 Q2 | 1.24 Million EUR | 113.9% |
| 2017 Q1 | -8.97 Million EUR | -6.57% |
| 2016 Q1 | -3.37 Million EUR | 39.09% |
| 2016 FY | -22.52 Million EUR | -32.02% |
| 2016 Q4 | -8.41 Million EUR | -42.08% |
| 2016 Q3 | -5.92 Million EUR | -23.23% |
| 2016 Q2 | -4.8 Million EUR | -42.66% |
| 2015 Q1 | -3.49 Million EUR | 25.08% |
| 2015 FY | -17.06 Million EUR | -30.6% |
| 2015 Q4 | -5.53 Million EUR | -62.93% |
| 2015 Q3 | -3.39 Million EUR | 26.71% |
| 2015 Q2 | -4.63 Million EUR | -32.48% |
| 2014 Q2 | -3.73 Million EUR | -43.16% |
| 2014 FY | -13.06 Million EUR | -51.85% |
| 2014 Q4 | -4.66 Million EUR | -127.61% |
| 2014 Q3 | -2.05 Million EUR | 45.08% |
| 2014 Q1 | -2.6 Million EUR | -23.68% |
| 2013 Q3 | -97.6 Thousand EUR | 97.56% |
| 2013 Q2 | -4 Million EUR | -67.07% |
| 2013 Q1 | -2.39 Million EUR | 0.0% |
| 2013 FY | -8.6 Million EUR | 35.28% |
| 2013 Q4 | -2.1 Million EUR | -2061.35% |
| 2012 FY | -13.29 Million EUR | -181.75% |
| 2011 FY | -4.71 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -46.25 Million USD | -818.906% |
| Jaguar Health, Inc. | -34.29 Million USD | -1139.535% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -150.116% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -648.866% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -50.633% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3659.278% |
| ContextLogic Inc. | -328 Million USD | -29.588% |
| MiMedx Group, Inc. | 37.11 Million USD | 1245.191% |
| MEI Pharma, Inc. | 14.54 Million USD | 3022.906% |
| AlloVir, Inc. | -181.33 Million USD | -134.405% |
| Novavax, Inc. | -566.51 Million USD | 24.971% |
| Aptorum Group Limited | -10.52 Million USD | -3939.111% |
| Ardelyx, Inc. | -63.27 Million USD | -571.738% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -107.339% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -15346.077% |
| Vaxcyte, Inc. | -468.04 Million USD | 9.186% |
| Precigen, Inc. | -88.92 Million USD | -377.997% |
| Pharming Group N.V. | -4.87 Million USD | -8610.834% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -154.046% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1328.448% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1974.32% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -80.413% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2088.885% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1648.697% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1648.697% |
| Bicycle Therapeutics plc | -189.94 Million USD | -123.774% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -55.125% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1350.432% |
| Acelyrin, Inc. | -422.06 Million USD | -0.707% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1022.419% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1046.797% |
| Senti Biosciences, Inc. | -92.72 Million USD | -358.388% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -270.339% |
| AbCellera Biologics Inc. | -237.2 Million USD | -79.189% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1140.403% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -147.435% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -13342.41% |
| Chimerix, Inc. | -93.06 Million USD | -356.723% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1187.208% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2323.451% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -842.934% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -738.477% |
| Elevation Oncology, Inc. | -45.44 Million USD | -835.304% |
| Alkermes plc | 414.12 Million USD | 202.639% |
| Fortress Biotech, Inc. | -142.34 Million USD | -198.611% |
| Fortress Biotech, Inc. | -142.34 Million USD | -198.611% |
| Agenus Inc. | -159.54 Million USD | -166.407% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -335.082% |
| Dyadic International, Inc. | -8.22 Million USD | -5064.793% |
| ImmuCell Corporation | -5.74 Million USD | -7294.628% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -35558.473% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -216.188% |
| Lantern Pharma Inc. | -17.87 Million USD | -2277.555% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2533.331% |
| Incyte Corporation | 620.52 Million USD | 168.498% |
| IO Biotech, Inc. | -91.44 Million USD | -364.824% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -482.426% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2015.746% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -700.071% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -229.526% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4899.988% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -406.529% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -11.709% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 15.718% |
| NextCure, Inc. | -67.63 Million USD | -528.427% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -3923.942% |
| Onconetix, Inc. | -36.03 Million USD | -1079.558% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -918.96% |
| Opthea Limited | -191.84 Million USD | -121.561% |
| PDS Biotechnology Corporation | -43.04 Million USD | -887.447% |
| PureTech Health plc | -146.19 Million USD | -190.733% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -417.116% |
| Seer, Inc. | -103.46 Million USD | -310.822% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3296146.435% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1610.872% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -10682.441% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1352.762% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -525.109% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -865.801% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -205.722% |
| ChromaDex Corporation | -5.59 Million USD | -7491.516% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -6061.916% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -266.235% |
| CRISPR Therapeutics AG | -222.53 Million USD | -91.001% |
| Precision BioSciences, Inc. | -43.73 Million USD | -871.852% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -123.11% |
| Innoviva, Inc. | 176.7 Million USD | 340.536% |
| Summit Therapeutics Inc. | -89.73 Million USD | -373.666% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -546.374% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -490.896% |
| ESSA Pharma Inc. | -32.13 Million USD | -1222.735% |
| GlycoMimetics, Inc. | -39.27 Million USD | -982.23% |
| GT Biopharma, Inc. | -13.57 Million USD | -3030.885% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -93.891% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 589.62% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -725.242% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4177.16% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -63.695% |
| Aptose Biosciences Inc. | -52.35 Million USD | -711.844% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2847.477% |
| Soligenix, Inc. | -7.69 Million USD | -5421.594% |
| Century Therapeutics, Inc. | -146.54 Million USD | -190.045% |
| Kura Oncology, Inc. | -165.8 Million USD | -156.356% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -354.802% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5009.376% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -17027.753% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -6455.352% |
| Autolus Therapeutics plc | -195.02 Million USD | -117.943% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -402.084% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -477.026% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1911.114% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -87.217% |
| GRI Bio, Inc. | -11.38 Million USD | -3632.757% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -9312.662% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -223.988% |
| IGM Biosciences, Inc. | -263.46 Million USD | -61.333% |
| INmune Bio, Inc. | -29.74 Million USD | -1329.168% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -284.26% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1016.337% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2559.987% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2595.16% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -595.684% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -295.314% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -54.0% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -109.179% |
| Verastem, Inc. | -92.08 Million USD | -361.588% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -801.769% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -130.823% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -259.055% |
| Histogen Inc. | -10.64 Million USD | -3893.695% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2647.221% |
| Surrozen, Inc. | -45.78 Million USD | -828.46% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2717.506% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8250.281% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -617.002% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -728.652% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1581.365% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -5468.685% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -148.156% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -777.331% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -443.506% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2692.558% |
| Apollomics, Inc. | -54.83 Million USD | -675.156% |
| Amarin Corporation plc | -67.58 Million USD | -528.882% |
| Mesoblast Limited | -58.79 Million USD | -622.946% |
| Turnstone Biologics Corp. | -59.03 Million USD | -620.032% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -156.781% |
| Synaptogenix, Inc. | -8.31 Million USD | -5012.539% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2814.089% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -363.567% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -8770.959% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -4713.019% |
| Exelixis, Inc. | 170.88 Million USD | 348.734% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1010.891% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -174.114% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 17.805% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3499.955% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -5185.426% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1317.161% |
| Gritstone bio, Inc. | -154.63 Million USD | -174.874% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -517.257% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2382.32% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2175.667% |
| Insmed Incorporated | -709.62 Million USD | 40.102% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2609.081% |
| MediWound Ltd. | -15.29 Million USD | -2679.915% |
| OmniAb, Inc. | -69.41 Million USD | -512.295% |
| Alector, Inc. | -151.74 Million USD | -180.117% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -293.626% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -715.082% |
| Zai Lab Limited | -366.57 Million USD | -15.952% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -34.179% |
| Aura Biosciences, Inc. | -84.99 Million USD | -400.111% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -73.137% |
| Immunic, Inc. | -99.22 Million USD | -328.377% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -196.909% |
| Veracyte, Inc. | -85.79 Million USD | -395.424% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -50.826% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2891.196% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -6070.91% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2161.787% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 173.464% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1569.937% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1195.431% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2160.045% |
| Galecto, Inc. | -39.9 Million USD | -965.152% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -910.241% |
| Fortrea Holdings Inc. | 63.1 Million USD | 773.612% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -202.644% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1371.878% |
| XBiotech Inc. | -37.51 Million USD | -1033.162% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -517.257% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -533.267% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -293.907% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1555.691% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -697.585% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 25.326% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -441.519% |
| Vaxxinity, Inc. | -58.28 Million USD | -629.26% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -309.848% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1810.064% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -391.864% |
| NexImmune, Inc. | -29.19 Million USD | -1356.022% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -7462.972% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2815.013% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 110.503% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1569.543% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3528.284% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -234.521% |
| Ainos, Inc. | -13.2 Million USD | -3118.509% |
| Pluri Inc. | -22.15 Million USD | -1818.264% |
| Prothena Corporation plc | -191.03 Million USD | -122.497% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -207.922% |
| Celularity Inc. | -192.28 Million USD | -121.049% |
| Rallybio Corporation | -78.93 Million USD | -438.5% |
| Cue Biopharma, Inc. | -52.14 Million USD | -715.066% |
| MeiraGTx Holdings plc | -137.06 Million USD | -210.117% |
| Omeros Corporation | -164.53 Million USD | -158.341% |
| Humacyte, Inc. | -100.04 Million USD | -324.849% |
| Immunocore Holdings plc | -59.64 Million USD | -612.584% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2190.258% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1636.099% |
| Blueprint Medicines Corporation | -486.27 Million USD | 12.591% |
| CalciMedica, Inc. | -21.87 Million USD | -1843.081% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -469.313% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -223.268% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -148.139% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -30.024% |
| Pulmatrix, Inc. | -14.74 Million USD | -2783.643% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1089.115% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -378.303% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 17.513% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -529.227% |
| Cytokinetics, Incorporated | -496.2 Million USD | 14.34% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1134.925% |
| Nutriband Inc. | -4.87 Million USD | -8624.455% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -874.592% |
| Vor Biopharma Inc. | -126.03 Million USD | -237.244% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 110.02% |
| Evogene Ltd. | -26.39 Million USD | -1510.583% |
| ProKidney Corp. | -151.52 Million USD | -180.52% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -558.633% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -5425.684% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 30.018% |
| CorMedix Inc. | -48.95 Million USD | -768.195% |
| BioLineRx Ltd. | -49.69 Million USD | -755.333% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -272.285% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1016.435% |
| Atai Life Sciences N.V. | -125.47 Million USD | -238.763% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -420.643% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -422.115% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -70.711% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1282.723% |
| MediciNova, Inc. | -9.9 Million USD | -4193.309% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -236.345% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5768.849% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1489.388% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -83.349% |
| Biomea Fusion, Inc. | -126.13 Million USD | -236.979% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -21.65% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1395.809% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -122.435% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -84.841% |
| Absci Corporation | -115.51 Million USD | -267.96% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1440.758% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -276.593% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -75.523% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1586.97% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -104.356% |
| Allakos Inc. | -196.05 Million USD | -116.8% |
| Imunon, Inc. | -21.03 Million USD | -1921.114% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -284.09% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 496.198% |
| BioAtla, Inc. | -129.68 Million USD | -227.75% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3499.955% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2582.882% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -29.692% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -917.886% |
| XOMA Corporation | -41.84 Million USD | -915.697% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -303.897% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -249.849% |
| aTyr Pharma, Inc. | -54.91 Million USD | -673.956% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -386.176% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -145.878% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -67.046% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1880.103% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -5075.474% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2429.15% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4806499.096% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 225.913% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6405.166% |
| UroGen Pharma Ltd. | -65.53 Million USD | -548.573% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -376.096% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5752.241% |
| Orgenesis Inc. | -53.63 Million USD | -692.47% |
| Entera Bio Ltd. | -8.89 Million USD | -4680.666% |
| GH Research PLC | -41.22 Million USD | -931.122% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1553.372% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -411.78% |
| Xencor, Inc. | -138.63 Million USD | -206.587% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -8146.04% |
| Replimune Group, Inc. | -234.77 Million USD | -81.047% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1877.789% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -2946.509% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6405.166% |
| Portage Biotech Inc. | -18.25 Million USD | -2228.653% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5768.849% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -304.959% |
| OncoCyte Corporation | -25.13 Million USD | -1590.997% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3659.879% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3609.93% |
| Purple Biotech Ltd. | 22.27 Million USD | 2008.531% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -5558.267% |
| scPharmaceuticals Inc. | -55.39 Million USD | -667.292% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2149.211% |
| HilleVax, Inc. | -133.34 Million USD | -218.759% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3427.67% |
| Tharimmune, Inc. | -9.45 Million USD | -4395.39% |
| Genprex, Inc. | -31.07 Million USD | -1267.791% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -125.857% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1254.651% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -55461.961% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -7703.476% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2698670.074% |
| Savara Inc. | -60 Million USD | -608.332% |
| Curis, Inc. | -48.33 Million USD | -779.436% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1278.245% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -8046.946% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -5740.992% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1459.813% |
| BeiGene, Ltd. | -1.2 Billion USD | 64.806% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2031.715% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 12.754% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -353.86% |
| Erasca, Inc. | -141.52 Million USD | -200.335% |
| bluebird bio, Inc. | -244.26 Million USD | -74.014% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -9289.252% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 318.601% |
| DBV Technologies S.A. | -76.43 Million USD | -456.114% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -9289.252% |
| Moderna, Inc. | -4.23 Billion USD | 89.973% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -897.557% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -6583.16% |
| Molecular Templates, Inc. | -10.46 Million USD | -3961.236% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -532.165% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -12.822% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -196.592% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -717.512% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -175.038% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -104.223% |
| MacroGenics, Inc. | -168.24 Million USD | -152.638% |
| RenovoRx, Inc. | -11.39 Million USD | -3629.809% |
| Adicet Bio, Inc. | -152.03 Million USD | -179.568% |
| Prime Medicine, Inc. | -191.29 Million USD | -122.199% |
| Aditxt, Inc. | -26.06 Million USD | -1530.888% |
| Adagene Inc. | -23.71 Million USD | -1691.954% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5714.546% |
| Quantum-Si incorporated | -111.17 Million USD | -282.338% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1243.052% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2815.734% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 448.361% |
| SciSparc Ltd. | -5.77 Million USD | -7262.706% |
| Vericel Corporation | -6.46 Million USD | -6475.634% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4810.079% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1738.481% |
| Generation Bio Co. | -138.56 Million USD | -206.755% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -411.922% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -391.613% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -76.295% |
| Invivyd, Inc. | -207.78 Million USD | -104.564% |
| Relay Therapeutics, Inc. | -373 Million USD | -13.954% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -4432.162% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2078.721% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4031.904% |
| 2seventy bio, Inc. | -216.7 Million USD | -96.144% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2064.908% |
| Clene Inc. | -40.54 Million USD | -948.468% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1665.311% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -675.693% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1489.388% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -21.422% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1057.162% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2743.833% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -309.875% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1150.071% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -149.621% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 37.886% |
| Evaxion Biotech A/S | -22.19 Million USD | -1814.894% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -415.949% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -90.499% |
| Trevena, Inc. | -35.28 Million USD | -1104.514% |
| Surrozen, Inc. | -45.78 Million USD | -828.46% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -431.677% |
| Cingulate Inc. | -22.75 Million USD | -1767.593% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 5773.372% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -851.595% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -5062.157% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -314.447% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -479.252% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -584.746% |
| Clearmind Medicine Inc. | -8.74 Million USD | -4762.51% |
| Kronos Bio, Inc. | -121.83 Million USD | -248.887% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -457.836% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -14392.028% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -321.563% |
| Statera Biopharma, Inc. | -98.34 Million USD | -332.207% |
| ImmunityBio, Inc. | -362.25 Million USD | -17.336% |
| Korro Bio, Inc. | -84.53 Million USD | -402.814% |
| Kineta, Inc. | -15.72 Million USD | -2603.358% |
| BioVie Inc. | -32.17 Million USD | -1220.865% |
| Codexis, Inc. | -68.06 Million USD | -524.438% |
| Celularity Inc. | -192.28 Million USD | -121.049% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -90.941% |
| Celcuity Inc. | -66.23 Million USD | -541.774% |
| Virax Biolabs Group Limited | -6.49 Million USD | -6442.766% |
| Cibus, Inc. | -318.88 Million USD | -33.293% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -888.486% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1155.907% |
| IN8bio, Inc. | -30.33 Million USD | -1301.091% |
| Kodiak Sciences Inc. | -277.32 Million USD | -53.27% |
| Annexon, Inc. | -143.72 Million USD | -195.742% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -243.36% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -557.502% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1713.04% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -20.162% |
| Eyenovia, Inc. | -25.4 Million USD | -1572.997% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1402.233% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -7542.017% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -437.132% |
| Arcellx, Inc. | -89.88 Million USD | -372.907% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -835.984% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -209.787% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1266.322% |
| Moolec Science SA | -6.65 Million USD | -6288.059% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -595.229% |
| Geron Corporation | -193.94 Million USD | -119.161% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -882.704% |
| Royalty Pharma plc | 1.49 Billion USD | 128.486% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -158.92% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4456.766% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1841.336% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -148.629% |
| Humacyte, Inc. | -100.04 Million USD | -324.849% |
| Structure Therapeutics Inc. | -102.77 Million USD | -313.572% |
| 89bio, Inc. | -151.2 Million USD | -181.11% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -430.436% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2823.308% |
| Genelux Corporation | -24.16 Million USD | -1658.945% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1152.982% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -147.481% |
| Notable Labs, Ltd. | -14.65 Million USD | -2799.973% |
| Liquidia Corporation | -73.38 Million USD | -479.212% |
| Mustang Bio, Inc. | -50.72 Million USD | -737.931% |
| Immunovant, Inc. | -282.7 Million USD | -50.349% |
| Quantum-Si incorporated | -111.17 Million USD | -282.338% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -444.216% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1898.632% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -316.666% |
| Acasti Pharma Inc. | -11.31 Million USD | -3657.505% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1754.4% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2559.987% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -98.571% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -11484.646% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2575.62% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1357.794% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -927.085% |
| PepGen Inc. | -84.76 Million USD | -401.438% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1334.474% |
| United Therapeutics Corporation | 1.18 Billion USD | 135.872% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1756.352% |
| Solid Biosciences Inc. | -104.31 Million USD | -307.467% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1195.56% |
| Immuneering Corporation | -58.41 Million USD | -627.663% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8250.281% |
| Silo Pharma, Inc. | -3.85 Million USD | -10924.221% |
| Belite Bio, Inc | -31.66 Million USD | -1242.203% |
| XOMA Corporation | -41.84 Million USD | -915.697% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -529.516% |
| Bionomics Limited | -17.89 Billion USD | 97.624% |
| Apogee Therapeutics, Inc. | -93 Million USD | -357.027% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1291.281% |
| uniQure N.V. | -282.87 Million USD | -50.262% |
| Cassava Sciences, Inc. | -105.95 Million USD | -301.152% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5714.546% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -228.213% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1208.407% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5015.676% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1345.991% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -7542.017% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2891.196% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -4681.741% |
| Altimmune, Inc. | -95.92 Million USD | -343.087% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -478.345% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1291.281% |
| Compugen Ltd. | -12.99 Million USD | -3171.621% |
| Peak Bio, Inc. | -1356.23 USD | -31340380.597% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -756.885% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1789.947% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -75.42% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1328.928% |
| Zura Bio Limited | -62.63 Million USD | -578.58% |
| PolyPid Ltd. | -22.86 Million USD | -1758.788% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2511.508% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1328.928% |
| Instil Bio, Inc. | -159.16 Million USD | -167.043% |
| Immunome, Inc. | -109.53 Million USD | -288.066% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -743.971% |
| Verona Pharma plc | -67.83 Million USD | -526.63% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1531.04% |
| Shattuck Labs, Inc. | -91.95 Million USD | -362.226% |
| CervoMed Inc. | -7.81 Million USD | -5340.352% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -481.383% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3090.819% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -782.32% |
| Moolec Science SA | -6.65 Million USD | -6288.059% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2484.13% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -214.323% |
| AnaptysBio, Inc. | -164.41 Million USD | -158.528% |
| Design Therapeutics, Inc. | -78.19 Million USD | -443.61% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -388.332% |
| NeurAxis, Inc. | -6.66 Million USD | -6277.813% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -949.53% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1060.892% |
| Achilles Therapeutics plc | -75.25 Million USD | -464.812% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1531.04% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3053.767% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 8343.277% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -14392.028% |
| Nutriband Inc. | -4.87 Million USD | -8624.455% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -283.687% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -666.558% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -736.118% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -543.049% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -685.338% |
| Palisade Bio, Inc. | -13.07 Million USD | -3152.096% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -836.046% |
| Beam Therapeutics Inc. | -176.48 Million USD | -140.841% |
| Neurogene Inc. | -55.58 Million USD | -664.71% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -289.403% |
| AEON Biopharma, Inc. | -48.42 Million USD | -777.675% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -339.509% |
| Sesen Bio, Inc. | -25.9 Million USD | -1540.546% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -408.864% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3276.917% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 7.71% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -486.768% |
| Athira Pharma, Inc. | -125.46 Million USD | -238.776% |
| Vaccinex, Inc. | -22.88 Million USD | -1757.326% |
| HCW Biologics Inc. | -25.71 Million USD | -1552.784% |
| XOMA Corporation | -41.84 Million USD | -915.697% |
| Nektar Therapeutics | -137.42 Million USD | -209.295% |
| Arvinas, Inc. | -401.5 Million USD | -5.865% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4806499.096% |
| Merus N.V. | -156.54 Million USD | -171.515% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -323.943% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1127.756% |
| Rezolute, Inc. | -70.42 Million USD | -503.566% |
| Clene Inc. | -40.54 Million USD | -948.468% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2495.169% |
| BeyondSpring Inc. | -23.11 Million USD | -1738.924% |
| Synlogic, Inc. | -55.16 Million USD | -670.561% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2270.735% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3826.912% |
| Peak Bio, Inc. | -1356.23 USD | -31340380.597% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -949.426% |
| Krystal Biotech, Inc. | -109.72 Million USD | -287.37% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -228.122% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -23.916% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -8856.031% |
| MannKind Corporation | 8.67 Million USD | 4998.006% |
| Ikena Oncology, Inc. | -75.41 Million USD | -463.598% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -4306.023% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -532.231% |
| Gossamer Bio, Inc. | -183.75 Million USD | -131.308% |
| CohBar, Inc. | -12.38 Million USD | -3331.053% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -737.964% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1440.758% |
| Legend Biotech Corporation | -439.48 Million USD | 3.285% |
| Mural Oncology plc | -194.63 Million USD | -118.379% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -533.05% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2532.653% |
| Disc Medicine, Inc. | -91.12 Million USD | -366.446% |
| Champions Oncology, Inc. | -7.35 Million USD | -5678.263% |
| REGENXBIO Inc. | -268.12 Million USD | -58.525% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3865.68% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -662.338% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -990.97% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -271.686% |
| Vaxart, Inc. | -83.34 Million USD | -409.975% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -4888.833% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -893.242% |
| Cellectis S.A. | -106.62 Million USD | -298.635% |
| Longeveron Inc. | -21.02 Million USD | -1921.252% |
| Repare Therapeutics Inc. | -116.22 Million USD | -265.715% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -58.705% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -461.9% |
| Revolution Medicines, Inc. | -487.18 Million USD | 12.754% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -6289.793% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -867.031% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -469.847% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -510.396% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3760.222% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 109.868% |
| Denali Therapeutics Inc. | -196.69 Million USD | -116.091% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4810.079% |
| Veru Inc. | -93.78 Million USD | -353.23% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1721.977% |
| Cingulate Inc. | -22.75 Million USD | -1767.593% |
| Passage Bio, Inc. | -108.38 Million USD | -292.151% |
| Context Therapeutics Inc. | -25.07 Million USD | -1595.272% |
| Exicure, Inc. | -14.99 Million USD | -2734.416% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -106.27% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -946.97% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -4274.311% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -130.558% |
| Nuvalent, Inc. | -149.49 Million USD | -184.329% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -5073.109% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -379.031% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1946.062% |
| OmniAb, Inc. | -69.41 Million USD | -512.295% |
| Anew Medical, Inc. | -1.3 Million USD | -32574.964% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3228.236% |
| Lipocine Inc. | -17.93 Million USD | -2270.476% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -520.392% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -458.159% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1016.337% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -975.338% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1798.897% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 26.697% |
| Ocugen, Inc. | -65.53 Million USD | -548.623% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -352.825% |
| Q32 Bio Inc. | -92.1 Million USD | -361.498% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1882.597% |
| Alumis Inc. Common Stock | -158.17 Million USD | -168.722% |
| Equillium, Inc. | -14.52 Million USD | -2826.932% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -581.103% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5278.087% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2153.096% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -805.303% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -291.873% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3450.948% |
| Dominari Holdings Inc. | -21.79 Million USD | -1850.124% |
| Edesa Biotech, Inc. | -9.22 Million USD | -4508.697% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1566.728% |
| Bio-Techne Corporation | 206.68 Million USD | 305.65% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -8.573% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 321.345% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -221.333% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1007.158% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -181.301% |
| Nkarta, Inc. | -131.65 Million USD | -222.863% |
| BioCardia, Inc. | -11.64 Million USD | -3550.369% |
| Iterum Therapeutics plc | -47.46 Million USD | -795.443% |